Nashville Biosciences
Erin Sundaram has a work experience primarily in the field of biosciences. Erin started their career as a Postdoctoral Scholar at The University of Chicago in April 2013, where they worked until June 2015. Erin then joined Nashville Biosciences in January 2016 as a Genomics Scientist, and held this position until June 2019. Erin was then promoted to the position of Senior Genomics Scientist at the same company, where they worked until October 2020. Currently, they are serving as the Scientific Project and Program Manager at Nashville Biosciences, a position they have held since November 2020.
Erin Sundaram pursued their higher education in the field of molecular biology. Erin obtained a Bachelor of Arts (B.A.) in Molecular, Cellular, and Developmental Biology from the University of Colorado Boulder. Following this, they went on to earn a Doctor of Philosophy (Ph.D.) in Molecular Genetics and Cell Biology from the University of Chicago, completing their studies between 2007 and 2013.
Nashville Biosciences
Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, Nashville Biosciences serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.